NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 143

Dettagli Bibliografici
Parent link:Progress in Neuro-Psychopharmacology and Biological Psychiatry.— .— Amsterdam: Elsevier Science Publishing Company Inc.
Vol. 143.— 2025.— Article number 111569, 9 p.
Altri autori: Fedorenko O. Yu. Olga Yurievna, Poltavskaya E. Evgeniya, Kornetova E. G. Elena Georgievna, Freidin M. B. Maxim, Bocharova A. V. Anna Vladimirovna, Boyko A, S, Anastasiya Sergeevna, Stepanov V. A. Vadim Anatoljevich, Bokhan N. A. Nikolay Aleksandrovich, Ivanova S. A. Svetlana Aleksandrovna, Strelnikov K. Kuzma
Riassunto:Title screen
Dopamine receptor inhibition underlies both the therapeutic and adverse effects of antipsychotics, but the mechanisms modulating these effects in patients with schizophrenia remain incompletely understood. Hyperprolactinemia (HPRL), a direct consequence of D2 dopamine receptor blockade, provides a unique clinical model to investigate how genetic variation in glutamatergic signaling influences the downstream effects of dopaminergic disruption. We hypothesized that polymorphisms in GRIN2A and GRIN2B, encoding NMDA glutamate receptor subunits, modify the neuroendocrine consequences of dopamine receptor inhibition. By studying antipsychotic-induced HPRL, we aimed to demonstrate that NMDA receptor genetic variants shape the functional outcomes of dopaminergic perturbation
Текстовый файл
AM_Agreement
Lingua:inglese
Pubblicazione: 2025
Soggetti:
Accesso online:https://doi.org/10.1016/j.pnpbp.2025.111569
Natura: Elettronico Capitolo di libro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=684627

MARC

LEADER 00000naa0a2200000 4500
001 684627
005 20260130145335.0
090 |a 684627 
100 |a 20260130d2025 k||y0rusy50 ba 
101 0 |a eng 
102 |a NL 
135 |a drcn ---uucaa 
181 0 |a i   |b  e  
182 0 |a b 
183 0 |a cr  |2 RDAcarrier 
200 1 |a NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia  |f Olga Yu. Fedorenko, Evgeniya G. Poltavskaya, Elena G. Kornetova [et al.] 
203 |a Текст  |c электронный  |b визуальный 
283 |a online_resource  |2 RDAcarrier 
300 |a Title screen 
330 |a Dopamine receptor inhibition underlies both the therapeutic and adverse effects of antipsychotics, but the mechanisms modulating these effects in patients with schizophrenia remain incompletely understood. Hyperprolactinemia (HPRL), a direct consequence of D2 dopamine receptor blockade, provides a unique clinical model to investigate how genetic variation in glutamatergic signaling influences the downstream effects of dopaminergic disruption. We hypothesized that polymorphisms in GRIN2A and GRIN2B, encoding NMDA glutamate receptor subunits, modify the neuroendocrine consequences of dopamine receptor inhibition. By studying antipsychotic-induced HPRL, we aimed to demonstrate that NMDA receptor genetic variants shape the functional outcomes of dopaminergic perturbation 
336 |a Текстовый файл 
371 0 |a AM_Agreement 
461 1 |t Progress in Neuro-Psychopharmacology and Biological Psychiatry  |c Amsterdam  |n Elsevier Science Publishing Company Inc. 
463 1 |t Vol. 143  |v Article number 111569, 9 p.  |d 2025 
610 1 |a Schizophrenia 
610 1 |a NMDA 
610 1 |a Glutamate 
610 1 |a Hyperprolactinemia 
610 1 |a Gene polymorphism 
610 1 |a GRIN2A 
610 1 |a GRIN2B 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
701 1 |a Fedorenko  |b O. Yu.  |c specialist in the field of ecology and life safety  |c Professor of Tomsk Polytechnic University, doctor of medical sciences  |f 1973-  |g Olga Yurievna  |9 17450 
701 1 |a Poltavskaya  |b E.  |g Evgeniya 
701 1 |a Kornetova  |b E. G.  |g Elena Georgievna 
701 1 |a Freidin  |b M. B.  |g Maxim 
701 1 |a Bocharova  |b A. V.  |g Anna Vladimirovna 
701 1 |a Boyko  |b A, S,  |g Anastasiya Sergeevna 
701 1 |a Stepanov  |b V. A.  |g Vadim Anatoljevich 
701 1 |a Bokhan  |b N. A.  |g Nikolay Aleksandrovich 
701 1 |a Ivanova  |b S. A.  |c specialist in the field of ecology and life safety  |c Professor of Tomsk Polytechnic University, doctor of medical sciences  |f 1964-  |g Svetlana Aleksandrovna  |3 (RuTPU)RU\TPU\pers\33859  |9 17448 
701 1 |a Strelnikov  |b K.  |g Kuzma 
801 0 |a RU  |b 63413507  |c 20260130  |g RCR 
856 4 0 |u https://doi.org/10.1016/j.pnpbp.2025.111569  |z https://doi.org/10.1016/j.pnpbp.2025.111569 
942 |c CF